Certificate under Regulation 74(5) of the SEBI (Depositories and participants) Regulation, 2018 for quarter ended 30th June 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30th June 2025 (Q1 FY26). The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Bigshare Services Pvt. Ltd. It confirms that no dematerialisation requests for equity shares were received from shareholders during the period 1st April 2025 to 30th June 2025. The filing was signed by Company Secretary Chintan Doshi and submitted to BSE on 11th July 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms the orderly functioning of share transfer and demat operations during the quarter.